Key result
This article reviews recent thoughts on the primary prevention of cardiovascular disease and the potential implementation of a heart polypill strategy in Iran.
This article discusses recent concepts in the primary prevention of cardiovascular disease and their potential implementation in Iran.
Supports polypill discussion for Iranian primary CVD prevention; leaves open local efficacy and implementation pending trials.
ardiovascular disease includes coronary heart disease and stroke. Together they are major causes of morbidity and mortality in many countries. In Iran, cardiovascular disease accounts for 45.7% of deaths. Cardiovascular disease is the well down which many Iranians will fall. Because cardiovascular disease is more common in older populations, it will become an increasing problem as the Iranian population ages. Is there anything we can do to mitigate the problem? The answer must be yes. Much of the epidemiology of cardiovascular disease is well understood. As a result we have a good understanding of how we could use this knowledge to prevent cardiovascular disease. This article will explain some of the most recent thoughts about how to prevent cardiovascular disease and how we could implement this in Iran.
No takes yet. Share an insight, caveat, or question.
Rastegarpanah et al. (2008) conducted a review in Cardiovascular disease. Heart polypill was evaluated. This article reviews recent thoughts on the primary prevention of cardiovascular disease and the potential implementation of a heart polypill strategy in Iran.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: